Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $64.53 USD
Change Today -0.58 / -0.89%
Volume 334.7K
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

amsurg corp (AMSG) Snapshot

Open
$64.80
Previous Close
$65.11
Day High
$64.84
Day Low
$64.18
52 Week High
04/15/15 - $66.42
52 Week Low
05/9/14 - $40.00
Market Cap
3.1B
Average Volume 10 Days
297.8K
EPS TTM
$2.10
Shares Outstanding
48.4M
EX-Date
--
P/E TM
30.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for AMSURG CORP (AMSG)

amsurg corp (AMSG) Related Bloomberg News

View More Bloomberg News

amsurg corp (AMSG) Related Businessweek News

No Related Businessweek News Found

amsurg corp (AMSG) Details

AmSurg Corp., through its subsidiaries, provides ambulatory and physician services in the United States. The company operates through two divisions, Ambulatory Services and Physician Services. The Ambulatory Services division acquires, develops, and operates ambulatory surgery centers (ASCs) in partnership with physicians. This division performs colonoscopy and other endoscopy procedures in the areas of gastroenterology; cataracts and retinal laser surgeries in the area of ophthalmology; and knee and shoulder arthroscopy and carpal tunnel repair in the area of orthopedics. The Physician Services division provides outsourced physician services to hospitals, ASCs, and other healthcare facilities primarily in the areas of anesthesiology services; children’s services, such as neonatal management services specializing in acute inpatient care and treatment of infants; emergency medicine services; and radiology services, including diagnostic, and interventional and tele radiology services to hospitals, imaging centers, and physician group practices, as well as other services. As of December 31, 2014, the company owned and operated 246 ASCs in 34 states and the District of Columbia in partnership with approximately 2,000 physicians; and provided physician services to approximately 320 healthcare facilities in 24 states. It offers its surgery center services directly to patients; referring physicians; and third-party payors, including health maintenance organizations, preferred provider organizations, other managed care organizations, and employers. The company was founded in 1992 and is headquartered in Nashville, Tennessee.

7,600 Employees
Last Reported Date: 02/27/15
Founded in 1992

amsurg corp (AMSG) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $736.5K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $442.0K
President of Ambulatory Services
Total Annual Compensation: $350.0K
Chief Accounting Officer and Senior Vice Pres...
Total Annual Compensation: $300.0K
Compensation as of Fiscal Year 2013.

amsurg corp (AMSG) Key Developments

AmSurg Corp. Declares Quarterly Preferred Stock Dividend, Payable on April 1, 2015

AmSurg Corp. announced that its board of directors has declared a quarterly dividend of $1.3125 per share in cash for the Company's 5.250% mandatory convertible preferred stock, series A-1. The dividend is payable on April 1, 2015, to shareholders of record as of March 15, 2015.

AmSurg Corp. Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-03-2015 03:25 PM

AmSurg Corp. Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-03-2015 03:25 PM. Venue: JW Marriott Grande Lakes, 4040 Central Florida Parkway, Orlando, FL 32837, United States. Speakers: Christopher A. Holden, Chief Executive Officer, President and Director, Claire M. Gulmi, Chief Financial Officer, Executive Vice President, Secretary and Director.

Amsurg Corp. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the First Quarter Ending March 31, 2015 and Full Year Ending December 31, 2015

AmSurg Corp. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported revenues of $645,619,000 against $279,095,000 a year ago. Net revenues were $581,811,000 against $279,095,000 a year ago. Operating income was $131,914,000 against $87,547,000 a year ago. Earnings from continuing operations before income taxes were $101,535,000 against $80,363,000 a year ago. Net earnings from continuing operations were $79,234,000 against $67,348,000 a year ago. Net earnings attributable to company shareholders were $27,379,000 against $19,558,000 a year ago. Net earnings attributable to company common shareholders were $25,115,000 against $19,558,000 a year ago. Earnings from continuing operations, net of income tax were $25,311,000 against $18,931,000 a year ago. Net earnings from continuing operations were $0.53 per share against $0.59 per share a year ago. Net earnings per share were $0.53 against $0.61 per share a year ago. Adjusted net earnings were $39,638,000 against $20,288,000 a year ago. Adjusted earnings per share were $0.77 against $0.63 per share a year ago. EBITDA was $103,066,000 against $47,460,000 a year ago. Adjusted EBITDA was $110,991,000 against $49,726,000 a year ago. Net cash flows provided by operating activities were $136,320,000 against $83,891,000 a year ago. Acquisition of property and equipment was $17,108,000 against $8,145,000 a year ago. For the year, the company reported revenues of $1,738,950,000 against $1,057,196,000 a year ago. Net revenues were $1,621,949,000 against $1,057,196,000 a year ago. Operating income was $394,364,000 against $332,672,000 a year ago. Earnings from continuing operations before income taxes were $294,192,000 against $303,147,000 a year ago. Net earnings from continuing operations were $246,089,000 against $254,493,000 a year ago. Net earnings attributable to company shareholders were $53,701,000 against $72,703,000 a year ago. Net earnings attributable to company common shareholders were $49,198,000 against $72,703,000 a year ago. Earnings from continuing operations, net of income tax were $50,777,000 against $71,009,000 a year ago. Net earnings from continuing operations were $1.28 per share against $2.22 per share a year ago. Net earnings per share were $1.24 against $2.28 per share a year ago. Adjusted net earnings were $114,162,000 against $74,833,000 a year ago. Adjusted earnings per share were $2.75 against $2.34 per share a year ago. EBITDA was $247,012,000 against $181,588,000 a year ago. Adjusted EBITDA was $304,482,000 against $187,972,000 a year ago. Net cash flows provided by operating activities were $412,371,000 against $332,824,000 a year ago. Acquisition of property and equipment was $40,217,000 against $28,856,000 a year ago. For the first quarter ending March 31, 2015, the company expects net earnings attributable to company shareholders of range between $18,500,000 to $20,000,000. Tax effect of range between $6,500,000 to $6,500,000. Adjusted net earnings of range between $28,250,000 to $29,750,000. Adjusted earnings per share of range between $0.55 to $0.58 per share. For the year ending December 31, 2015, the company expects net earnings attributable to company shareholders of range between $127,500,000 to $131,500,000. Tax effect of range between $26,240,000 to $26,240,000. Adjusted net earnings of range between $166,860,000 to $170,860,000. Adjusted earnings per share of range between $3.24 to $3.32 per share. Net earnings attributable to company shareholders of range between $127,500,000 or $131,500,000. EBITDA of range between $429,400,000 to $435,400,000. Adjusted EBITDA of range between $445,000,000 to $451,000,000.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMSG:US $64.53 USD -0.58

AMSG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
HealthSouth Corp $45.74 USD -0.57
LifePoint Hospitals Inc $75.49 USD +0.68
Providence Service Corp/The $47.04 USD -1.54
Surgical Care Affiliates Inc $38.46 USD -0.53
Team Health Holdings Inc $62.04 USD -0.21
View Industry Companies
 

Industry Analysis

AMSG

Industry Average

Valuation AMSG Industry Range
Price/Earnings 50.6x
Price/Sales 1.9x
Price/Book 2.0x
Price/Cash Flow 27.4x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMSURG CORP, please visit www.amsurg.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.